Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves’ Ophthalmopathy

33 patients with active, moderate-severe Graves’ ophthalmopathy (GO) received 4.5 g methylprednisolone for 12 weeks and were divided by efficacy into two groups (responsive and unresponsive). All patients and 10 controls underwent orbital MRI examination at baseline. No significant difference was se...

Full description

Saved in:
Bibliographic Details
Main Authors: Lingling Xu, Linna Li, Cuihua Xie, Meiping Guan, Yaoming Xue
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2017/3196059
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849473342309924864
author Lingling Xu
Linna Li
Cuihua Xie
Meiping Guan
Yaoming Xue
author_facet Lingling Xu
Linna Li
Cuihua Xie
Meiping Guan
Yaoming Xue
author_sort Lingling Xu
collection DOAJ
description 33 patients with active, moderate-severe Graves’ ophthalmopathy (GO) received 4.5 g methylprednisolone for 12 weeks and were divided by efficacy into two groups (responsive and unresponsive). All patients and 10 controls underwent orbital MRI examination at baseline. No significant difference was seen in baseline clinical characteristics between the two GO groups. The values of exophthalmos were higher in both GO groups than in the control and were higher in the responsive group versus the unresponsive group. Compared to the unresponsive group, the responsive group had a thicker inferior rectus as well as thinner orbital fat. The inferior rectus/fat ratio was significantly higher in the responsive group versus the unresponsive group. Multivariate logistic regression analysis showed that the exophthalmos value and inferior rectus/fat ratio were significantly associated with the response to glucocorticoid (GC). ROC analysis revealed that the cut-off points of the inferior rectus/fat ratio combined with the exophthalmos value to indicate efficacy were 1.42 and 20.78. For moderate-severe GO patients with CAS > 3, the combined inferior rectus/fat ratio and exophthalmos value in MRI may be a valuable indicator to predict the response to GC therapy.
format Article
id doaj-art-c8f9f4c9740f4be68623ba40478530d4
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-c8f9f4c9740f4be68623ba40478530d42025-08-20T03:24:11ZengWileyInternational Journal of Endocrinology1687-83371687-83452017-01-01201710.1155/2017/31960593196059Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves’ OphthalmopathyLingling Xu0Linna Li1Cuihua Xie2Meiping Guan3Yaoming Xue4Department of Endocrinology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Endocrinology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Endocrinology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Endocrinology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, ChinaDepartment of Endocrinology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China33 patients with active, moderate-severe Graves’ ophthalmopathy (GO) received 4.5 g methylprednisolone for 12 weeks and were divided by efficacy into two groups (responsive and unresponsive). All patients and 10 controls underwent orbital MRI examination at baseline. No significant difference was seen in baseline clinical characteristics between the two GO groups. The values of exophthalmos were higher in both GO groups than in the control and were higher in the responsive group versus the unresponsive group. Compared to the unresponsive group, the responsive group had a thicker inferior rectus as well as thinner orbital fat. The inferior rectus/fat ratio was significantly higher in the responsive group versus the unresponsive group. Multivariate logistic regression analysis showed that the exophthalmos value and inferior rectus/fat ratio were significantly associated with the response to glucocorticoid (GC). ROC analysis revealed that the cut-off points of the inferior rectus/fat ratio combined with the exophthalmos value to indicate efficacy were 1.42 and 20.78. For moderate-severe GO patients with CAS > 3, the combined inferior rectus/fat ratio and exophthalmos value in MRI may be a valuable indicator to predict the response to GC therapy.http://dx.doi.org/10.1155/2017/3196059
spellingShingle Lingling Xu
Linna Li
Cuihua Xie
Meiping Guan
Yaoming Xue
Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves’ Ophthalmopathy
International Journal of Endocrinology
title Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves’ Ophthalmopathy
title_full Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves’ Ophthalmopathy
title_fullStr Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves’ Ophthalmopathy
title_full_unstemmed Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves’ Ophthalmopathy
title_short Thickness of Extraocular Muscle and Orbital Fat in MRI Predicts Response to Glucocorticoid Therapy in Graves’ Ophthalmopathy
title_sort thickness of extraocular muscle and orbital fat in mri predicts response to glucocorticoid therapy in graves ophthalmopathy
url http://dx.doi.org/10.1155/2017/3196059
work_keys_str_mv AT linglingxu thicknessofextraocularmuscleandorbitalfatinmripredictsresponsetoglucocorticoidtherapyingravesophthalmopathy
AT linnali thicknessofextraocularmuscleandorbitalfatinmripredictsresponsetoglucocorticoidtherapyingravesophthalmopathy
AT cuihuaxie thicknessofextraocularmuscleandorbitalfatinmripredictsresponsetoglucocorticoidtherapyingravesophthalmopathy
AT meipingguan thicknessofextraocularmuscleandorbitalfatinmripredictsresponsetoglucocorticoidtherapyingravesophthalmopathy
AT yaomingxue thicknessofextraocularmuscleandorbitalfatinmripredictsresponsetoglucocorticoidtherapyingravesophthalmopathy